Todd Usen bought ADGM once, on Dec 12, 2025

Todd Usen is the Chief Executive Officer and Director of Adagio Medical Holdings, Inc. (Nasdaq: ADGM), appointed effective December 13, 2024, following the departure of founder Olav Bergheim.( He leads the company's efforts in commercializing its VT Cryoablation System with vCLAS catheter, based on ultra-low-temperature cryoablation (ULTC) technology for treating ventricular tachycardia, including initial commercial activities in Europe and the FULCRUM-VT trial in the US.(

Usen brings extensive experience in the medical device industry, having most recently served as President and CEO of Minerva Surgical, where he drove restructuring, financings, and growth.( Previously, he was CEO of Activ Surgical, securing FDA/CE clearances and raising over $92 million, and President of Olympus Corporation's Medical Systems Group, managing a $2 billion+ business with strategic expansions and M&A.( His career includes executive roles at Smith+Nephew and Boston Scientific.( Currently, he also serves as Executive Chairman of Rob Surgical, Chairman of NeoPredics, and Director of Alesi Surgical.( As CEO, Usen recently purchased 207,315 shares of ADGM stock for approximately $225,973 on December 12, 2025.(

Written by Perplexity from public sources.